Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.09
+0.33 (5.64%)
At close: May 12, 2025, 4:00 PM
6.09
0.00 (0.08%)
After-hours: May 12, 2025, 4:20 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $527.24 million as of May 12, 2025. Its market cap has decreased by -63.07% in one year.
Market Cap
527.24M
Enterprise Value
-111.60M
1-Year Change
-63.07%
Ranking
Category
Stock Price
$6.09
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $527.24M, an increase of 363.71%. That is a compound annual growth rate of 17.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 498.70M | -26.37% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |